Visualization and quantification of intestinal transit and motor function by real‐time tracking of 19F labeled capsules in humans
暂无分享,去创建一个
[1] H. Parkman,et al. Wireless Capsule Motility: Comparison of the SmartPill® GI Monitoring System with Scintigraphy for Measuring Whole Gut Transit , 2009, Digestive Diseases and Sciences.
[2] M. Camilleri,et al. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. , 2006, Gastroenterology.
[3] Pascal Spincemaille,et al. Kalman filtering for real‐time navigator processing , 2008, Magnetic resonance in medicine.
[4] Vikram D Kodibagkar,et al. 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. , 2005, Current medicinal chemistry.
[5] V. Schlageter,et al. Colonic movements in healthy subjects as monitored by a Magnet Tracking System , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[6] V. Schlageter,et al. Magnetic pill tracking: a novel non‐invasive tool for investigation of human digestive motility , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[7] R. Hauser,et al. Duodenal levodopa infusion for the treatment of Parkinson’s disease , 2007, Expert opinion on pharmacotherapy.
[8] Basil Künnecke,et al. Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance , 2002, Magnetic resonance in medicine.
[9] Eric T Ahrens,et al. In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.
[10] M. Krafft,et al. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. , 2001, Advanced drug delivery reviews.
[11] Fernando Vilariño,et al. Intestinal Motility Assessment With Video Capsule Endoscopy: Automatic Annotation of Phasic Intestinal Contractions , 2010, IEEE Transactions on Medical Imaging.
[12] S. Caruthers,et al. Molecular MR Imaging with Paramagnetic Perfluorocarbon Nanoparticles , 2008 .
[13] E. Benarroch,et al. Neural control of the gastrointestinal tract: Implications for Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[14] R. Fisher,et al. Gastric emptying of a non‐digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[15] Hansen Mb,et al. Small intestinal manometry. , 2002 .
[16] E. Quigley,et al. Gastric and small intestinal motility in health and disease. , 1996, Gastroenterology clinics of North America.
[17] M. Hansen,et al. Small intestinal manometry. , 2002, Physiological research.
[18] S. Flaim. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.
[19] R. Mattrey,et al. Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial. , 1994, Radiology.
[20] Lutz Trahms,et al. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.
[21] Samuel A Wickline,et al. Quantitative magnetic resonance fluorine imaging: today and tomorrow. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[22] H. Mönnikes,et al. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] May C. Chen. An Illustrated Guide to Gastrointestinal Motility , 1989, The Yale Journal of Biology and Medicine.
[24] E. Quigley,et al. Disturbances in small bowel motility. , 1999, Bailliere's best practice & research. Clinical gastroenterology.
[25] T. Dinan,et al. Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.
[26] M. Bogataj,et al. Gastric emptying of non-disintegrating solid drug delivery systems in fasted state: relevance to drug dissolution , 2010, Expert opinion on drug delivery.
[27] R. Mason,et al. Comparison of 1H blood oxygen level–dependent (BOLD) and 19F MRI to investigate tumor oxygenation , 2009, Magnetic resonance in medicine.
[28] S. Caruthers,et al. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. , 2005, Current topics in developmental biology.
[29] Philippe C. Cattin,et al. Intensity-based elastic registration incorporating anisotropic landmark errors and rotational information , 2009, International Journal of Computer Assisted Radiology and Surgery.
[30] C. Gorter,et al. Negative result of an attempt to observe nuclear magnetic resonance in solids , 1942 .
[31] M. Camilleri,et al. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[32] Clive G. Wilson,et al. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.